Sponsored diagnostic testing programs for Developmental and Epileptic Encephalopathy (DEE)
Developmental and epileptic encephalopathy (DEE) refers to a group of severe early-onset epilepsies characterized by frequent, difficult-to-control seizures and developmental delays. These conditions are often caused by genetic variants that disrupt normal brain function. Early diagnosis helps guide management, counseling, and potential treatment options.
2 programs found for Developmental and Epileptic Encephalopathy (DEE)
The Behind the Seizure® program provides no-charge access to Invitae’s comprehensive epilepsy panel for children under 10 with unprovoked seizure onset between ages 2–5. The panel evaluates 300+ epilepsy-related genes that can influence management decisions. Early genetic insights may support faster diagnosis, targeted treatment planning, and improved care coordination.
This program provides access to genetic testing for pediatric patients under 18 who present with an unprovoked seizure. The panel evaluates key epilepsy-associated genes to support diagnostic confirmation, inform prognosis, and guide clinical management. Testing is available to eligible patients when ordered by a licensed healthcare provider.
